Evidence map›Paper›PMID 41063133›Full record

SynthesisBMC health services research2025

Barriers and facilitators associated with long-term follow-up care for childhood, adolescent, and young adult cancer survivors: a systematic review.

Ismay A E de Beijer, Jessica Trollip, Selina R van den Oever, Renée L Mulder, Leontien C M Kremer, Gill Levitt, Edit Bardi, Adela Cañete Nieto, Desiree Grabow, Riccardo Haupt and 14 more

Abstract readSystematic Review
In one paragraph

Synthesis in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Dietary intervention among young cancer survivors within the CARE for CAYA program.Journal of cancer survivorship : research and practice · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Ismay A E de BeijerPrincess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
Jessica TrollipPrincess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
Selina R van den OeverPrincess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
Renée L MulderPrincess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
Leontien C M KremerPrincess Máxima Center for Pediatric Oncology, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.
Gill LevittGreat Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Edit BardiSt Anna Children's Hospital, Vienna, Austria,, Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria.
Adela Cañete NietoHospital Universitario y Politécnico La Fe, Valencia, Spain.
Desiree GrabowDivision of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), German Childhood Cancer Registry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Riccardo HauptDepartment of Hematology/Oncology IRCCS, DOPO Clinic, Istituto Giannina Gaslini, Genova, Italy.
Lars HjorthDepartment of Clinical Sciences Lund, Lund University, Skane University Hospital, Paediatric, Lund, Sweden.
Anna-Liesa FilbertDivision of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), German Childhood Cancer Registry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Tomas KepakInternational Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
Anita KienesbergerChildhood Cancer International, Vienna, Austria.
Thorsten LangerPaediatric Oncology and Haematology, Universitaetsklinikum Schleswig-Holstein, Clinic for Children and Adolescents, Campus Luebeck, Luebeck, Germany.
Jacqueline LoonenDepartment of Hematology, Radboud University Medical Centre, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.
Gisela MichelFaculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
Monica MuracaDepartment of Hematology/Oncology IRCCS, DOPO Clinic, Istituto Giannina Gaslini, Genova, Italy.
Jelena RasconCenter for Pediatric Oncology and Hematology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Roderick SkinnerGreat North Children's Hospital, Translational and Clinical Research Institute, Royal Victoria Infirmary, Wolfson Childhood Cancer Research Centre, Newcastle, United Kingdom.
Anne UyttebroeckPediatric Hematology and Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Elvira C van DalenPrincess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
Saskia M F Pluijm *Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
Helena J H van der Pal *Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. h.j.h.vanderpal@prinsesmaximacentrum.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOptimal long-term follow-up (LTFU) care for survivors of childhood, adolescent and young adult (CAYA) cancer can improve or maintain their quality of life by prevention and early treatment of late effects. However, optimal LTFU care is not provided to all CAYA cancer survivors. This systematic review sought to identify associated barriers, facilitators and other factors of LTFU care for CAYA cancer survivors worldwide.

methodsWe included barriers and facilitators from a previously published guideline in 2017, and performed a systematic search using PubMed/Medline to identify studies between 1-1-2017 and 5-6-2025 examining barriers, facilitators and other factors associated with LTFU care from the perspectives of CAYA cancer survivors, diagnosed with cancer ≤25 years of age, healthcare providers (HCPs), and hospital managers involved in the provision of LTFU care for CAYA cancer survivors. Qualitative and (semi)quantitative (survey) studies with multivariable analyses were eligible for inclusion. Standardised evidence tables were made independently by one author and checked by another author to extract relevant information.

resultsThe search yielded 4,677 unique records, of which 230 were selected for full-text screening and 51 articles were included in this systematic review. Twenty-two studies were qualitative, twenty-two were quantitative and seven used a mixed methods design. The previous published guideline provided 19 barriers and 5 facilitators until 2017. Within the current review, 85 barriers, 63 facilitators, and 23 other factors were reported. Main barriers included lack of knowledge, information and awareness of LTFU care, lack of resources, poor transition from paediatric to adult care, and the lack of national/regional LTFU care programmes or clinics. Main facilitators included a treatment summary/survivorship care plan, involvement of multidisciplinary specialists, education to improve late effects knowledge, a clear contact/information point, and improved communication. Regarding other factors, treatment with radiation only, older attained age, age at diagnosis, and non-white descent were most frequently associated with less LTFU care. The main factor associated with more LTFU care by survivors was the number of late effects.

conclusionsWe encourage raising awareness, provision of appropriate information, treatment summaries and survivorship care plans, and advocacy for supportive policies and funding in order to optimise LTFU care and facilitate engagement for CAYA cancer survivors.

Indexed as

AftercareCancer SurvivorsHealth Services AccessibilityLong-Term CareNeoplasmsAdolescentChildHumansYoung AdultAftercareBarriers and facilitatorsCancer survivorsFactorsLong-term follow up carePaediatric oncologySurvivorship

Identifiers

PMID41063133
PMCPMC12506384

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.